Cell & Gene Therapies: A Regulatory Update

Return to Insights Center

Related Insights

Report

New Medicines, Novel Insights: Accelerating development of cell and gene therapies

May 22, 2023

Article

Three ways to improve your chances that insurers will pay for a new CGT

Feb 18, 2021

Blog

Studying multiple versions of a cellular or gene therapy product in an early-phase clinical trial

Nov 19, 2021

Playbook

Mitigating risk, protecting potential: Practical strategies that position cell and gene therapy development for success

Mar 28, 2023

Article

Expedited Pathways Comparisons - US EU CHN

Oct 19, 2021

Blog

Maintaining Data Integrity for Quality and Compliance – Essential Despite Pandemic Disruptions

May 16, 2022

Article

New FDA Guidance Addresses the Need for Data-Generation Strategies Across the Drug Development Lifecycle

May 10, 2022

Blog

Chris Learn joins Parexel as Head of the Cell and Gene Center of Excellence

Apr 4, 2022

Video

On-demand webinar: An expert guide to EU-CTR

Mar 10, 2022

Article

New endpoints for early-stage cancer are gaining regulatory traction

Jan 28, 2022

Video

Creating EU-CTR compliant and patient-friendly lay language summaries (LLS)

Jan 26, 2022

Blog

Biosimilar Development: Are therapeutic clinical trials needed?

Nov 16, 2021